In view of the fact that cancer treatment is extremely expensive, the central government has taken an important decision. According to government sources, from now on, the trade margin on cancer drugs will be limited to 30 percent. The main objective of this step is to reduce the retail price of highly expensive life-saving medicines that patients have to take.
Usually, the gap between the production cost and the selling price of medicines puts a financial burden on patients. Due to trade margins at various levels, the prices of these medicines are often beyond the reach of ordinary patients. With the government setting this new limit, manufacturers and sellers will not be able to profit beyond a certain threshold.
Background: ১০ শতাংশলৈ ল'ৱাৰ বেৰিফিশিয়াৰী অ'নাৰশ্বিপ থকা প্ৰতিষ্ঠানৰ বাবে সহজ হ'ব এফডিআই প্ৰক্ৰিয়া
This decision will have a direct impact on the country's health sector. Experts believe that this measure will bring some level of control to the long-standing concerns regarding the expensive treatment and medication costs for cancer. With the reduction in treatment costs, it is likely that cancer treatment will become more accessible for middle-class and poor families.
In the coming days, the government is expected to release more details regarding the implementation process and the list of medicines. As a result of this policy, the prices of existing expensive medicines in the market may be revised. It has paved the way for significant relief for families affected by cancer.